4.20000 USD
0.16
3.67%
Last update Dec 15, 11:51 AM EST
Pre-market
Day range
4.20000
4.45000
Previous close
4.36000
Open
4.45000
Access this stock data via API
Subscribe
NervGen Pharma Corp.
4.20
0.16
3.67%

Financials

Income statement

Fundamentals currency is CAD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 3.2M 2.0M 2.3M 3.3M
Selling general and admin 1.3M 2.7M 2.1M 1.6M
Other operating expenses
Operating income -4.5M -4.7M -4.4M -4.9M
Non operating interest income
Income 56.0K 63.1K 78.3K 124.3K
Expense
Other income expense 1.4M -2.0M 1.4M -1.4M
Pretax income -3.0M -6.6M -2.9M -6.3M
Tax provision
Net income -3.0M -6.6M -2.9M -6.3M
Basic EPS -0.1 -0.1 -0.1
Diluted EPS -0.1 -0.1 -0.1
Basic average shares 53.1M 52.3M 51.3M
Diluted average shares 53.1M 52.3M 51.3M
EBITDA -5.9M -2.7M -5.8M -3.5M
Net income from continuing op. -3.0M -6.6M -2.9M -6.3M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Pre-market

Exchange is currently open for pre-market.
Main market opens in 17 minutes

09:12
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
06:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 17:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).